Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deep Versus Moderate Neuromuscular Blocking in Open Hysterectomy
NCT07485517Recruiting
- Sponsor
- Menoufia University
- Start
- Jun 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of rocuronium (2 arms), sponsored by Menoufia University. Primary endpoint: Change in serum levels of inflammatory cytokines. Started Jun 2026; status: recruiting.
02
Drugs
rocuronium
Beyond the preview
Go deeper on NCT07485517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07485517.